CA
NZ
UK
AU
IND
US
Kuros Biosciences AG recently highlighted some significant strategic developments during its Q2 earnings call. The company discussed its ongoing initiatives aimed at accelerating product development and enhancing its market positioning. Management emphasized the importance of collaborative partnerships, indicating that these alliances are designed to …
Kyntra Bio, Inc. (NASDAQ: KYNB) reported significant financial results for the second quarter of 2026, highlighting a substantial shift to profitability. This dramatic turnaround emphasizes Kyntra Bio's strategic advancements in its oncology and rare diseases portfolio designed to deliver value to patients and investors.
Liquidia Corporation reported a remarkable surge in net sales for Q2 2026, with revenues from YUTREPIA hitting $170.4 million, an impressive 31% increase over the previous quarter. The growth reflects the product's dominant position in the inhaled prostacyclin market, which itself grew by approximately …
MapLight Therapeutics, Inc. (NASDAQ: MPLT) has successfully secured $150 million through a private placement financing, marking a significant boost to its cash reserves. This financing plan, unveiled on August 13, is aimed at enhancing the organization’s financial stability and funding its operational needs. By …
Fortress Biotech, Inc. reported total net revenue of $18.7 million for the second quarter of 2026, marking a 14% increase compared to the same quarter in 2025. This growth illustrates the company’s successful strategy in advancing its product portfolio and achieving significant financial milestones. …
Fortress Biotech demonstrated solid growth in the second quarter of 2026, with total revenue reaching $18.5 million, a 23% increase from $15 million in the same period last year. This uptick was significantly driven by the commercial success of its dermatological product, Emrosi, which …
Freenome, Inc. finalized its merger with Perceptive Capital Solutions Corp on July 20, 2026, marking a significant milestone for the business. The merger was structured under the terms outlined in a business combination agreement initiated on December 5, 2025, and subsequently amended on July …
Health In Tech, Inc. (NASDAQ: HIT) conducted a conference call on August 13, 2026, to discuss its financial and operational results for the quarter that ended on June 30, 2026. The meeting aimed to provide investors with a comprehensive overview of the company's performance …
Health In Tech, Inc. (NASDAQ: HIT) conducted a conference call on August 13, 2026, to discuss its financial and operational results for the quarter that ended on June 30, 2026. The meeting aimed to provide investors with a comprehensive overview of the company's performance …
Heartflow, Inc. (NASDAQ: HTFL) has reported an impressive 48% increase in revenue for the second quarter of 2026, signaling strong operational performance. This surge in revenue reflects the company's effective strategies andDemandfor its offerings. As a direct result of this positive financial outcome, Heartflow …
Please wait processing your request...